|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Amblyopia | |||||
| Strabismus | |||||
| Refractive Error | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Refractive Errors | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Cranial Nerve Diseases | |||||
| Eye Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Ocular Motility Disorders | |||||
| Sensation Disorders | |||||
| Signs and Symptoms | |||||
| Vision Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Vision Screening | |||||
| 5 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||